Enders et al. (37) reported that patients with active juvenile dermatomyositis had elevated levels of three pro-inflammatory biomarkers (CXCL10, TNFR2, and Galectin-9) that highly correlated with disease activity. This evidence concerns the gene CXCL10 and juvenile dermatomyositis.